A newly approved pancreatic cancer drug is offering new hope for some patients, but its nearly half-million-dollar price tag is raising questions about who will be able to access it and how families might afford it.

As the Las Vegas Raiders prepare to face the San Francisco 49ers, brain health remains an important topic in football.

One UNLV doctor and professor is applauding the breakthrough results as a personalized mRNA cancer vaccine has shown promise for preventing recurrence of melanoma, according to a new trial from drugmakers Merck and Moderna.

A neonatal intensive care unit that serves some of the region’s most vulnerable newborns is set to close in Henderson, reducing the number of NICUs available in Clark County.

A UNLV professor and doctor is explaining what he says will be the long-term impact of President Donald Trump's executive order on childhood vaccine recommendations.

A UNLV professor and doctor is weighing in on the science behind the pandemic, as partisan politics are playing out in Washington.

Dr. Marc Kahn, professor and chief of hematology at UNLV's Department of Internal Medicine at the Kirk Kerkorian School of Medicine, joined ARC Las Vegas and Evan Schreiber to clarify how safe and effective peptides really are and why they have become so popular in wellness, fitness, and anti-aging circles.

The notion of testosterone as an all-purpose elixir for strength and vitality is not supported by science. But medical experts say a decade of new research has bolstered the case for testosterone’s benefits for sexual health while allaying concerns about its impact on the heart.

New research is drawing attention to a critical link between women’s reproductive health and long-term heart health, with studies suggesting that some common gynecological conditions may raise the risk of serious cardiovascular problems later in life.

Results from a late-stage clinical trial of the pill daraxonrasib offers new hope for a notoriously deadly disease, doctors say.

The Food and Drug Administration has approved a new sunscreen active ingredient for use in over-the-counter products, marking the first time in roughly 20 years that Americans will have access to a new formula.

Research shows that a novel pill helped people with advanced pancreatic cancer live longer, raising hopes of long-needed better treatments for one of the deadliest types of cancer. The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades.